"ZAI" の関連情報検索結果
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecas...

Triple meeting 2025 – Zai discloses pivotal DLL3 plans | ApexOnco - Clinical Trials news and anal...

Triple meeting 2025 – Zai discloses pivotal DLL3 plans | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab Receives Approval In China For Schizophrenia Drug COBENFY - Nasdaq

Zai Lab Receives Approval In China For Schizophrenia Drug COBENFY Nasdaq
Does Zai Lab’s Steep 86.2% Slide Mask a Long Term Value Opportunity? - Yahoo Finance

Does Zai Lab’s Steep 86.2% Slide Mask a Long Term Value Opportunity? Yahoo Finance
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Cla...

Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia Business Wire
Amgen-Zai stomach cancer candidate takes a turn with 'attenuated' OS benefits at final phase 3 an...

Amgen-Zai stomach cancer candidate takes a turn with 'attenuated' OS benefits at final phase 3 analysis Fierce Biotech
Me ya faru Abba zai koma APC ya bar Kwankwaso a NNPP? - BBC

Zai Yang ’27 launches Polar Plate website - The Bowdoin Orient

Zai Yang ’27 launches Polar Plate website The Bowdoin Orient
Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy) - Seeking ...

Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy) Seeking Alpha
Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, ...

Zai Lab Secures China's Approval For Schizophrenia Therapy In Adults - Nasdaq

Zai Lab Secures China's Approval For Schizophrenia Therapy In Adults Nasdaq
World Lung 2025 – Ideaya challenges Zai Lab | ApexOnco - Clinical Trials news and analysis - Onco...

World Lung 2025 – Ideaya challenges Zai Lab | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab Limited (ZLAB): A Bull Case Theory - Yahoo Finance

Zai Lab Limited (ZLAB): A Bull Case Theory Yahoo Finance
Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503, an IL-13/IL-...

ASCO 2025 – Amgen gets one over on Zai Lab | ApexOnco - Clinical Trials news and analysis - Oncol...

ASCO 2025 – Amgen gets one over on Zai Lab | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Could Zai Lab’s (ZLAB) Pipeline Milestone Reveal Shifting Dynamics in Its Oncology Growth Narrati...

Could Zai Lab’s (ZLAB) Pipeline Milestone Reveal Shifting Dynamics in Its Oncology Growth Narrative? Yahoo Finance
Amgen and Zai Lab eye a gastric niche | ApexOnco - Clinical Trials news and analysis - Oncology P...

Amgen and Zai Lab eye a gastric niche | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab (NasdaqGM:ZLAB): Exploring Valuation After a 23% One-Month Share Price Decline - Yahoo Fi...

Zai Lab (NasdaqGM:ZLAB): Exploring Valuation After a 23% One-Month Share Price Decline Yahoo Finance
Zai Lab shares Phase 1 data for lung cancer drug that could spar with Amgen’s Imdelltra - Endpoin...

Zai Lab shares Phase 1 data for lung cancer drug that could spar with Amgen’s Imdelltra Endpoints News
"Zai yi tazarce": Shugaban Hukuma ya ja kunnen Barau kan neman kujerar Abba - Legit.ng

"Zai yi tazarce": Shugaban Hukuma ya ja kunnen Barau kan neman kujerar Abba Legit.ng
BBC Studios Productions CEO Touts ‘Dancing With the Stars’ TikTok, YouTube Success, ‘Ghosts’ - Th...

BBC Studios Productions CEO Touts ‘Dancing With the Stars’ TikTok, YouTube Success, ‘Ghosts’ The Hollywood Reporter
Zai Lab Announces Updates to China’s National Reimbursement Drug List - Business Wire

Zai Lab Announces Updates to China’s National Reimbursement Drug List Business Wire
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data Announce...

A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data Announcement Yahoo Finance
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates Business Wire
Ana sa ran Abba zai sanar da komawa APC ranar Laraba, zai bar Kwankwaso a NNPP - Legit.ng

Ana sa ran Abba zai sanar da komawa APC ranar Laraba, zai bar Kwankwaso a NNPP Legit.ng
Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter R...

Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter Results Yahoo Finance
Rumored Trump Move Rattles China-Based Biotech Stocks - Investor's Business Daily

Rumored Trump Move Rattles China-Based Biotech Stocks Investor's Business Daily
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November...

Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 Business Wire
Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag Yahoo Finance
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pel...

BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race - Deadline

BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race Deadline
What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting The...

What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates Yahoo Finance
Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 - Fierce Biotech

Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 Fierce Biotech
Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates Business Wire
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrati...

Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint - Clinical Trials Arena

Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint Clinical Trials Arena
Zai Lab Announces Participation in Investor Conferences in September 2025 - Business Wire

Zai Lab Announces Participation in Investor Conferences in September 2025 Business Wire
Zai Lab Takes Lead In DLL3 Lung Cancer ADC Race - Citeline News & Insights

Zai Lab Takes Lead In DLL3 Lung Cancer ADC Race Citeline News & Insights
China’s First Police Corgi Has 400,000 Followers and a Nose for Trouble - The New York Times

China’s First Police Corgi Has 400,000 Followers and a Nose for Trouble The New York Times
Zai Lab Announces Participation in Investor Conferences in November and December 2025 - Business ...

Zai Lab Announces Participation in Investor Conferences in November and December 2025 Business Wire
#ESMO25: Amgen, Zai Lab detail reduced survival benefit in stomach cancer trial - Endpoints News

#ESMO25: Amgen, Zai Lab detail reduced survival benefit in stomach cancer trial Endpoints News
Stocks Showing Improved Relative Strength: Zai Lab ADR - Investor's Business Daily

Stocks Showing Improved Relative Strength: Zai Lab ADR Investor's Business Daily
'An ce komai ya kammala,' Bayanai game da komawar Abba APC daga NNPP - Legit.ng

'An ce komai ya kammala,' Bayanai game da komawar Abba APC daga NNPP Legit.ng
Fu Zai, China's first police corgi, racks up followers on social media - NPR

Fu Zai, China's first police corgi, racks up followers on social media NPR
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device...

Man Utd na son karɓo aron Gallagher, Endrick zai koma Lyon - BBC

Man Utd na son karɓo aron Gallagher, Endrick zai koma Lyon BBC
Zai Lab stock hits 52-week low at 21.22 USD - Investing.com

Zai Lab stock hits 52-week low at 21.22 USD Investing.com
Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges...

Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges Yahoo Finance
Zai Lab looks towards an accelerated pathway | ApexOnco - Clinical Trials news and analysis - Onc...

Zai Lab looks towards an accelerated pathway | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab under pressure over clinical results and rival drugs - thebambooworks.com

Zai Lab under pressure over clinical results and rival drugs thebambooworks.com
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor ...

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August ...

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 Business Wire
Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha

Zai Lab Limited Is Well Positioned For Long-Term Growth Seeking Alpha
Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts - Yahoo Finance

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts Yahoo Finance
Voices and media frames in the public debate on artificial intelligence: comparing results from m...

Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus

Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est GuruFocus
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Tr...

Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer i...

Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong Yahoo Finance
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment - Yahoo Finance

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment Yahoo Finance
Zai Lab's TIVDAK Approved In Hong Kong For Advanced Cervical Cancer Treatment - Nasdaq

Zai Lab's TIVDAK Approved In Hong Kong For Advanced Cervical Cancer Treatment Nasdaq
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Ant...

Abubuwan da ke faruwa a Najeriya da sassan duniya - BBC

Adnan Zai - Crain's Cleveland Business

Adnan Zai Crain's Cleveland Business
Zai Lab Forms Scientific Advisory Board - citybiz

Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 - Endpoints News

Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 Endpoints News
Stocks Showing Rising Market Leadership: Zai Lab ADR Earns 82 RS Rating - Investor's Business Daily

Stocks Showing Rising Market Leadership: Zai Lab ADR Earns 82 RS Rating Investor's Business Daily
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - BioSpace

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates BioSpace
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2...

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 Business Wire
DL Zai'Vion Meads has fall visits scheduled - 247Sports

Zai'Canya Benjamin Obituary - Houma, LA - Dignity Memorial

Zai'Canya Benjamin Obituary - Houma, LA Dignity Memorial
'Za mu tallafa masa,' Muaz Magaji kan maganar komawar Abba APC - Legit.ng

'Za mu tallafa masa,' Muaz Magaji kan maganar komawar Abba APC Legit.ng
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Yahoo Finance

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? Yahoo Finance
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Pat...

Zai Calliste: Company Bound - Dance Australia

Zai Calliste: Company Bound Dance Australia
Zai Bennett unveils BBCS Productions leadership changes - Televisual

Zai Bennett unveils BBCS Productions leadership changes Televisual
Zai Lab Ltd (1ZLB) Gets a Buy from UBS - The Globe and Mail

Zai Lab Ltd (1ZLB) Gets a Buy from UBS The Globe and Mail
Kone zai koma Man U, Chelsea da Leeds United na zawarcin McAtee - BBC

Kone zai koma Man U, Chelsea da Leeds United na zawarcin McAtee BBC
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update...

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates Business Wire
Shin rikicin gabashin Kwango zai kawo karshe? - DW

Zai Lab takes a second punt on MediLink | ApexOnco - Clinical Trials news and analysis - Oncology...

Zai Lab takes a second punt on MediLink | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
FDA grants orphan drug status to Zai Lab's lung cancer treatment - Pharmaceutical Technology

FDA grants orphan drug status to Zai Lab's lung cancer treatment Pharmaceutical Technology
Energy, atmosphere impressed DL Zai’Vion Meads during trip to Madison - 247Sports

Energy, atmosphere impressed DL Zai’Vion Meads during trip to Madison 247Sports
Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st

Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) simplywall.st
Ahmed al-Sharaa zai gana da Donald Trump - DW

At just 21, this Queenslander has danced his way to the London ballet - Australian Broadcasting C...

At just 21, this Queenslander has danced his way to the London ballet Australian Broadcasting Corporation
Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seek...

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) Seeking Alpha
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-3 - GuruFocus

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-3 GuruFocus
UBS Reiterates Buy on ZAI LAB But Cuts TP to HKD20.1 - AASTOCKS.com

UBS Reiterates Buy on ZAI LAB But Cuts TP to HKD20.1 AASTOCKS.com
Zai Lab stock hits 52-week low at 19.5 USD - Investing.com India

Zai Lab stock hits 52-week low at 19.5 USD Investing.com India
Trump zai gana da Putin a Amurka - DW

Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $69 - 富途牛牛

Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $69 富途牛牛
Manzon EU zai je Washington kan batun harajin Trump - DW

Indiana makes a great impression on 2027 three-star DL Zai'Vion Meads during gameday visit - 247S...

Indiana makes a great impression on 2027 three-star DL Zai'Vion Meads during gameday visit 247Sports
Trump zai shirya taro tsakanin Putin da Zelensky - DW

'Zan dauki sojoji miliyan 1,' Kwankwaso kan magance rashin tsaro - Legit.ng

'Zan dauki sojoji miliyan 1,' Kwankwaso kan magance rashin tsaro Legit.ng
Wa zai amfana da ganawar Trump da Putin? - DW

Zai Labs announces positive results in China arm of Phase III cervical cancer trial - Clinical Tr...

Zai Labs announces positive results in China arm of Phase III cervical cancer trial Clinical Trials Arena
Vertex out-licenses povetacicept to Zai Lab - The Pharma Letter

Vertex out-licenses povetacicept to Zai Lab The Pharma Letter
Zai Lab (ZLAB) Seeks Label Expansion for Cancer Treatment in Chi - GuruFocus

Zai Lab (ZLAB) Seeks Label Expansion for Cancer Treatment in Chi GuruFocus
Trump ya ce zai soke yarjejeniyoyi da EU da wasu kasashe - DW
